NEPH - Nephros - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NEPH is currently covered by 1 analysts with an average price target of $4.94. This is a potential upside of $3.04 (160%) from yesterday's end of day stock price of $1.9.

Nephros's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of NEPH is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for NEPH is $5, Lowest price target is $5, average price target is $5.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 12-Nov-2024. First documented stock forecast 24-Oct-2019.

Best performing analysts who are covering NEPH - Nephros:

Marc Wiesenberger Robert Wasserman

Currently out of the existing stock ratings of NEPH, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.1 (163.16%)

$5

5 months 27 days ago
(12-Nov-2024)

0/2 (0%)

$3.36 (204.88%)

Buy

$5.25

$3.73 (245.39%)

$8

3 years 4 days ago
(05-May-2022)

0/4 (0%)

$2.72 (107.51%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NEPH (Nephros) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on NEPH (Nephros) with a proven track record?

MARC WIESENBERGER

Which analyst has the current lower performing score on NEPH (Nephros) with a proven track record?

ROBERT WASSERMAN

Which analyst has the most public recommendations on NEPH (Nephros)?

Marc Wiesenberger has 4 price targets and 2 ratings on NEPH

Which analyst is the currently most bullish on NEPH (Nephros)?

Marc Wiesenberger with highest potential upside - $3.73

Which analyst is the currently most reserved on NEPH (Nephros)?

Robert Wasserman with lowest potential downside - $3.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?